For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Market Segment as follows:
- Regenerative Medicine
- In-vitro & In-vivo Diagnostics
- Drug Delivery
- Clinical Cardiology
- GE Healthcare
- Johnson & Johnson
- Mallinckrodt plc
- Merck & Co. Inc.
- Nanosphere Inc.
- Pfizer Inc.
- Sigma-Tau Pharmaceuticals Inc.
- Smith & Nephew PLC
- Stryker Corp
- Teva Pharmaceutical Industries Ltd.
- UCB (Union chimique belge) S.A
The main contents of the report including:
Section 1: Product definition, type and application, global and China market overview;
Section 2: Global and China Market competition by company;
Section 3: Global and China sales revenue, volume and price by type;
Section 4: Global and China sales revenue, volume and price by application;
Section 5: China export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.